Skip to main content
Jamie W. Rhoads
( out of 178 reviews )

Jamie W. Rhoads, MD

Languages spoken: English

Clinical Locations

  • Dr. Jamie Rhoads has specialized interest in medical dermatology and infectious disease dermatology. She has completed a two-year fellowship in psoriasis and published research in this area. She enjoys caring for patients with any general dermatologic concerns.

    Board Certification

    American Board of Dermatology (Dermatology)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 178 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 15, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Even though we are still seeking answers I don't feel alone, I know that Dr. Rhoads will continue to help us navigate this unknown path

    August 05, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Solid

    July 27, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Great

    July 15, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Smart, patient and understanding. Also, if I have any questions, I know I can call her and her office and get a quick answer. This is very comforting.

    July 14, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I felt I was in good hands and that she cared

    July 14, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Absolutely could not ask for a better Dr.

    July 03, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Exceptional!

    July 03, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Rhoads is the very best! I cant say enough good things about her.

    May 26, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Our conversations made me feel I could trust her with my health.

  • Dr. Jamie Rhoads has specialized interest in medical dermatology and infectious disease dermatology. She has completed a two-year fellowship in psoriasis and published research in this area. She enjoys caring for patients with any general dermatologic concerns.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah Resident
    Clinical Investigation - University of Utah M.S.C.I
    Research Fellow Dermatology - University of Utah Research Fellow
    Internal Medicine - University of Florida College of Medicine-Jacksonville Intern
    Professional Medical Medicine - University of Florida College of Medicine M.D.
    Majors: Chemistry, Biochemistry; Minors: Biology, Math - Florida State University B.S.

    Selected Publications

    Journal Article

    1. Rhoads JLW, Christensen L, Westerdahl S, Stevens V, Chapman WW, Conway M (2024). Automatic Extraction of Skin and Soft Tissue Infection Status from Clinical Notes. Stud Health Technol Inform, 310, 579-583. (Read full article)
    2. Rhoads JLW, Malatestinic WN, Burge R, Ganz ML, Duffin KC (2023). Factors Associated with Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data. J Psoriasis Psoriatic Arthritis, (0).
    3. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Biber JE, Hess R, Rhoads JL, Secrest AM (2023). Quality of Life and Avoiding Triggers of Atopic Dermatitis Flares: A Qualitative Study. Skinmed, 21(4), 233-235. (Read full article)
    4. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    5. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2023). Atopic Dermatitis: A Qualitative Study on the Burdens of Living with Itchiness. J Clin Aesthet Dermatol, 16(7), 22-25. (Read full article)
    6. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JLW (2022). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA Dermatol, 158(11), 1321-1323. (Read full article)
    7. Snyder AM, Brandenberger AU, Taliercio VL, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2022). Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis. Int J Behav Med. (Read full article)
    8. Skemp-Dymond G, Lebiedz-Odrobina D, Zuromski LM, Rhoads JLW, Tebo AE (2021). Assessment of a line immunoassay for the detection of mi-2 antibodies. Am J Clin Pathol, 157, 506-509. (Read full article)
    9. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families. JMIR Dermatol, 4(2), e29826. (Read full article)
    10. Flint ND, Rhoads JLW, Carlisle R, Ferrel M, Hopkins ZH, Secrest AM (2021). The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone. Dermatol Online J, 27(8). (Read full article)
    11. Beshay A, Petersen M, Rhoads JLW (2021). Severe EGFR inhibitor-induced acneiform eruption responding to dapsone. Dermatol Online J, 27(7). (Read full article)
    12. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42–48.
    13. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42-48. (Read full article)
    14. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of pain from atopic dermatitis: Interview and focus group study with patients and their families. JMIR Dermatol, 4(2).
    15. Rhoads JLW, Willson TM, Sutton JD, Spivak ES, Samore MH, Stevens VW (2019). Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clin Infect Dis, 72(4), 675-681. (Read full article)
    16. Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, Gelfand JM, Krueger GG, Duffin KC (2013). Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol, 69(6), 931-7. (Read full article)
    17. Duffin KC, Woodcock J, Krueger GG (2010). Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association. Dermatol Ther, 23(2), 101-13. (Read full article)

    Case Report

    1. Dao DP, Sahni VN, Sahni DR, Abbott J, Rhoads JLW (2021). Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis. JAAD Case Rep, 16, 124-126. (Read full article)
    2. Lo MC, Woodcock JL (2011). Case of EBV-induced adrenal insufficiency, cardiac tamponade, and pleural effusions. Fed Pract, 28(7), 23-27.

    Letter

    1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
  • News & Podcasts